Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ISRCTN17231220) titled 'Process Optimization Of the Medicines' pAthway in nursing Homes' on May 7.

Study Type: Interventional

Study Design: Multi-arm pre-post cluster randomized controlled trial (Other, Safety, Efficacy)

Primary Sponsor: KU Leuven

Condition: Improvement of the quality of the medicines' pathway in nursing homes Other

Intervention: Nursing homes (NHs) are allocated to one of the four support programs, receiving different formats and intensities of support during one year (2025).

NHs in Program 1 gain access to a (mostly digital) toolbox. NHs in Program 2 gain access to that same toolbox, and take part in intervisi...